thiazoles has been researched along with Alveolar Bone Atrophy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, PC; Chong, LY; Kao, MJ; Tsai, SC | 1 |
| Chang, CY; Chang, PC; Chao, YC; Jheng, YH; Lee, N; Liu, DM; Yang, C; Yu, MC; Yu, SH; Yu, XH | 1 |
| Baba, R; Haneji, T; Inagaki, Y; Morimoto, H; Nagata, T; Ochiai, K; Okamura, H; Shinohara, H; Teramachi, J; Yang, D | 1 |
| Amaral, SL; Cestari, TM; Dionísio, TJ; Machado, MA; Oliveira, TM; Sakai, VT; Santos, CF; Taga, R | 1 |
| Casati, MZ; de Toledo, S; Duarte, PM; Gurgel, BC; Nociti, FH; Sallum, AW; Sallum, EA | 1 |
| Alencar, VB; Bezerra, MM; Brito, GA; de Lima, V; Ribeiro, RA; Rocha, FA; Vieira, IB | 1 |
| Atilla, G; Baylas, H; Buduneli, N; Luoto, H; Sorsa, T; Vardar, S | 1 |
1 trial(s) available for thiazoles and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
Topics: Adult; Alveolar Bone Loss; Chronic Disease; Combined Modality Therapy; Cyclooxygenase Inhibitors; Dental Plaque Index; Dental Scaling; Double-Blind Method; Female; Fluorescent Antibody Technique; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Isoenzymes; Male; Matched-Pair Analysis; Matrix Metalloproteinase 8; Meloxicam; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Placebos; Root Planing; Statistics, Nonparametric; Thiazines; Thiazoles | 2002 |
6 other study(ies) available for thiazoles and Alveolar Bone Atrophy
| Article | Year |
|---|---|
N-Phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)-AGE receptor axis to modulate experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Blood Glucose; Cell Adhesion Molecules; Cell Culture Techniques; Cell Line; Cell Survival; Collagen Type I; Disease Models, Animal; Disease Progression; Fibronectins; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Immunohistochemistry; Male; Periodontal Ligament; Periodontitis; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles; Tumor Necrosis Factor-alpha | 2014 |
pH-Responsive Hydrogel With an Anti-Glycation Agent for Modulating Experimental Periodontitis.
Topics: Alveolar Bone Loss; Animals; Hydrogel, Polyethylene Glycol Dimethacrylate; Periodontitis; Rats; Rats, Sprague-Dawley; Thiazoles | 2016 |
PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivo.
Topics: Alveolar Bone Loss; Animals; Cell Line; eIF-2 Kinase; Indoles; Lipopolysaccharides; MAP Kinase Signaling System; Mice; NF-kappa B; Osteoclasts; Osteogenesis; Periodontal Diseases; Rats; Thiazoles | 2017 |
COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Blotting, Western; Cyclooxygenase 2 Inhibitors; Disease Progression; Male; Meloxicam; Periodontitis; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Statistics, Nonparametric; Thiazines; Thiazoles; Vascular Endothelial Growth Factor A | 2008 |
Impact of an anti-inflammatory therapy and its withdrawal on the progression of experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Isoenzymes; Ligation; Male; Meloxicam; Periodontitis; Prostaglandin-Endoperoxide Synthases; Random Allocation; Rats; Rats, Wistar; Statistics, Nonparametric; Thiazines; Thiazoles | 2004 |
Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Alveolar Process; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cell Count; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Indomethacin; Injections, Subcutaneous; Isoenzymes; Leukocyte Count; Leukocytes, Mononuclear; Leukocytosis; Male; Meloxicam; Molar; Neutrophils; Osteoclasts; Periodontitis; Peroxidases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stomach; Thiazines; Thiazoles; Tooth Cervix | 2000 |